1308 related articles for article (PubMed ID: 26484443)
1. Immunological landscape and immunotherapy of hepatocellular carcinoma.
Prieto J; Melero I; Sangro B
Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):681-700. PubMed ID: 26484443
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial immunotherapy strategies for hepatocellular carcinoma.
Tagliamonte M; Petrizzo A; Tornesello ML; Ciliberto G; Buonaguro FM; Buonaguro L
Curr Opin Immunol; 2016 Apr; 39():103-13. PubMed ID: 26851637
[TBL] [Abstract][Full Text] [Related]
3. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
4. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
Fu Y; Liu S; Zeng S; Shen H
J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
Harding JJ; El Dika I; Abou-Alfa GK
Cancer; 2016 Feb; 122(3):367-77. PubMed ID: 26540029
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for hepatocellular carcinoma.
Li S; Yang F; Ren X
Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
[TBL] [Abstract][Full Text] [Related]
7. The yin and yang of evasion and immune activation in HCC.
Makarova-Rusher OV; Medina-Echeverz J; Duffy AG; Greten TF
J Hepatol; 2015 Jun; 62(6):1420-9. PubMed ID: 25733155
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint therapy in liver cancer.
Xu F; Jin T; Zhu Y; Dai C
J Exp Clin Cancer Res; 2018 May; 37(1):110. PubMed ID: 29843754
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies.
Giraud J; Chalopin D; Blanc JF; Saleh M
Front Immunol; 2021; 12():655697. PubMed ID: 33815418
[TBL] [Abstract][Full Text] [Related]
11. Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges.
Wang L; Wang FS
Hepatol Int; 2019 Sep; 13(5):521-533. PubMed ID: 31352593
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.
Wirth TC
Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):101-10. PubMed ID: 24410473
[TBL] [Abstract][Full Text] [Related]
13. Potential of immunotherapy for hepatocellular carcinoma.
Breous E; Thimme R
J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
[TBL] [Abstract][Full Text] [Related]
14. [Hepatocellular carcinoma - from immunobiology to immunotherapy].
Flecken T; Schmidt N; Spangenberg HC; Thimme R
Z Gastroenterol; 2012 Jan; 50(1):47-56. PubMed ID: 22222798
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.
Liu Z; Liu X; Liang J; Liu Y; Hou X; Zhang M; Li Y; Jiang X
Front Immunol; 2021; 12():765101. PubMed ID: 34675942
[TBL] [Abstract][Full Text] [Related]
16. Perspectives of immunotherapy in hepatocellular carcinoma (HCC).
Büttner N; Schmidt N; Thimme R
Z Gastroenterol; 2016 Dec; 54(12):1334-1342. PubMed ID: 27936483
[TBL] [Abstract][Full Text] [Related]
17. Novel immunotherapeutic approaches for hepatocellular carcinoma treatment.
Busato D; Mossenta M; Baboci L; Di Cintio F; Toffoli G; Dal Bo M
Expert Rev Clin Pharmacol; 2019 May; 12(5):453-470. PubMed ID: 30907177
[TBL] [Abstract][Full Text] [Related]
18. Advances in immunotherapy for hepatocellular carcinoma.
Sangro B; Sarobe P; Hervás-Stubbs S; Melero I
Nat Rev Gastroenterol Hepatol; 2021 Aug; 18(8):525-543. PubMed ID: 33850328
[TBL] [Abstract][Full Text] [Related]
19. Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.
Tagliamonte M; Mauriello A; Cavalluzzo B; Ragone C; Manolio C; Petrizzo A; Buonaguro L
Cancer Lett; 2020 Mar; 473():25-32. PubMed ID: 31875523
[TBL] [Abstract][Full Text] [Related]
20. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges.
Liu X; Qin S
Oncologist; 2019 Feb; 24(Suppl 1):S3-S10. PubMed ID: 30819826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]